He has demonstrated authority and independence as guest scientific advisor for the preparation of the USA Affordable Care Act (ACA) on comparative efficacy research, representing France alongside 3 other members from the United Kingdom, Germany and Australia, and as guest member of the nomination committee in China for the CAS institute for translational medicine (Canton).